SWOT Analysis for Medifast Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Company with Low Debt
Book Value per share Improving for last 2 years
Top Gainers

Promoter decreasing their shareholding
Stocks in the PE Sell Zone
Stocks with Quarter Change % less than Industry
PE higher than Industry PE
Negative profit growth, promoters decreasing shareholding QoQ
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
High PE (PE > 40)
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Near 52 Week Low
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Declining Revenue every quarter for the past 4 quarters
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter